Join our daily newsletter At The Bell to receive exclusive market insights
- PainChek (PCK) receives a $392,820 grant from the Western Australia State Government’s Future Health Research and Innovation Fund
- The grant is for the company’s project to develop a specific version of PainChek for non-verbal children living with a disability
- Additionally, it is validation and evidence of the need for technology-enabled tools such as PainChek for the assessment of pain in non-verbal children
- As such, the project will address a significant unmet need and opens opportunities to expand PainChek’s market opportunities
- Shares in PainChek are up 12.1 per cent and trading at 3.7 cents as of 12:49 pm AEST
PainChek (PCK) has been awarded a $392,820 grant from the Western Australia State Government’s Future Health Research and Innovation Fund.
The grant is for the company’s project to develop a specific version of PainChek for non-verbal children living with a disability.
The company was one of 17 awarded in the McGowan Government’s inaugural Innovation Seed Fund 2022 with more than $8 million distributed under the program, focused on novel ideas that have the potential to improve the health and wellbeing of Western Australians.
The project known as “Detecting pain in kids who can’t tell you it hurts: PainChek for children with disabilities” is led by Associate Professor Jenny Downs, from Telethon Kids Institute on behalf of the Centre for Child Health Research, University of Western Australia along with PainChek’s Professor Jeff Hughes.
Additionally, the grant is validation and evidence of the need for technology-enabled tools such as PainChek for the assessment of pain in non-verbal children.
Professor Hughes said pain amongst children living with disability is common and can have a significant negative impact on their quality of life.
“For those caring for these children, knowing when they are in pain can be challenging,” he said.
“This project aims to create a tool that will allow rapid and accurate detection of pain, thus improving pain management.”
As such, the project will address a significant unmet need and opens opportunities to expand PainChek’s market opportunities.
The company said PainChek is already used in over 800 aged care facilities globally and has transformed pain management in residential aged care homes across both Australia and in the UK.
Shares in PainChek were up 12.1 per cent and trading at 3.7 cents held steady 3.3 cents as of 12:49 pm AEST.
